Brain Aging and Neurodegeneration: Alzheimer’s Mechanisms, Cognitive Reserve, and Evidence-Based Strategies
Normal brain aging (not disease): processing speed declines with age; working memory capacity slightly decreases; but vocabulary, procedural skills, and crystallized intelligence typically remain relatively stable to age 70–80. Normal vs. Alzheimer’s: normal “benign senescent forgetfulness” doesn’t impair daily function; Alzheimer’s core feature is progressive episodic memory decline (inability to retain new information) plus at least one other cognitive domain impairment.
## Alzheimer’s Molecular Mechanisms
**Amyloid-β (Aβ) hypothesis** (long-dominant): APP (amyloid precursor protein) abnormal cleavage produces Aβ42 fragments accumulating in the brain, forming senile plaques triggering neuroinflammation and synaptic damage. However, multiple Aβ-clearing drug trials (including many monoclonal antibodies) failed to halt cognitive decline. In 2023, lecanemab (Leqembi) received FDA approval — the first drug proven to both clear Aβ and statistically significantly slow early Alzheimer’s cognitive decline (~27% effect), though clinical significance and safety (bleeding risk) remain debated.
**Tau hypothesis**: intraneuronal tau protein hyperphosphorylation causes neurofibrillary tangles, impairing axonal transport and causing neuronal death. Tau pathology typically correlates more directly with cognitive impairment than Aβ plaques.
## Cognitive Reserve: Education, Intellectual Activity, and Dementia Protection
**Cognitive Reserve** hypothesis (Yaakov Stern): higher education, sustained intellectual activity (learning new skills, reading, chess), and rich social networks increase neural connection density and efficiency, giving the brain greater buffering capacity against Alzheimer’s pathology — at equal pathology severity, high-reserve individuals show later or milder symptoms. The [Lancet 2020 dementia prevention review](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30367-6/fulltext) identified 12 modifiable dementia risk factors including low education, hearing loss, hypertension, obesity, physical inactivity, diabetes, depression, smoking, social isolation, excessive alcohol, air pollution, and head injury.
